Description

Sitazit-D 10mg/100mg Tablet is a combination antidiabetic medicine containing Dapagliflozin 10mg (an SGLT2 inhibitor) and Sitagliptin 100mg (a DPP-4 inhibitor). Together, they work by different mechanisms to provide better control of type 2 diabetes mellitus:

Dapagliflozin lowers blood sugar by preventing glucose reabsorption in the kidneys, leading to glucose elimination through urine.
Sitagliptin increases incretin hormone activity, boosting insulin release after meals and reducing glucose production in the liver.

This dual approach helps in better glycemic control, weight management, and reduced risk of diabetes complications.

Uses of Sitazit-D 10mg/100mg Tablet

Management of type 2 diabetes mellitus in adults
Helps control fasting and postprandial (after-meal) blood glucose levels
Provides added benefits in weight reduction
May help in lowering the risk of cardiovascular and kidney-related complications in diabetes

How to Use

Take the tablet once daily or as prescribed by your doctor.
Can be taken with or without food.
Maintain a diabetic-friendly diet, exercise, and regular blood sugar monitoring while on treatment.
Do not stop the medicine without consulting your doctor.

Side Effects

Common:

Increased urination
Urinary tract infections
Headache
Nasopharyngitis (cold-like symptoms)

Less common but serious:

Dehydration or low blood pressure
Genital infections
Pancreatitis (rare but possible)
Hypoglycemia (when taken with other antidiabetics)

Precautions & Warnings

Prescription Required – use only under medical supervision.
Not recommended in patients with type 1 diabetes or diabetic ketoacidosis.
Use with caution in those with kidney or liver problems.
Stay well hydrated to avoid dehydration.
Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Monitor blood sugar, kidney function, and blood pressure regularly during treatment.

Conclusion

Sitazit-D 10mg/100mg Tablet (Dapagliflozin 10mg + Sitagliptin 100mg) is a powerful dual-action therapy for type 2 diabetes management. By targeting blood sugar through both the kidneys and incretin pathway, it helps patients achieve better glucose control, weight benefits, and long-term protection against complications when combined with a healthy lifestyle and medical supervision.